Chronic hypersensitivity pneumonitis

Hypersensitivity pneumonitis (HSP) is a common interstitial lung disease resulting from inhalation of a large variety of antigens by susceptible individuals. The disease is best classified as acute and chronic. Chronic HSP can be fibrosing or not. Fibrotic HSP has a large differential diagnosis and...

Full description

Saved in:
Bibliographic Details
Published in:Journal of asthma and allergy 2016-01, Vol.9, p.171-181
Main Authors: Pereira, Carlos Ac, Gimenez, Andréa, Kuranishi, Lilian, Storrer, Karin
Format: Article
Language:English
Subjects:
Airway management
Alveoli
Alveolitis
Antigens
Bronchus
Care and treatment
Cluster analysis
Cytokines
Development and progression
Differential diagnosis
Disease susceptibility
Extrinsic allergic alveolitis
Fibrosis
Hypersensitivity
Hypersensitivity pneumonitis
Inflammation
Inhalation
Lung diseases
Lung transplantation
Medical prognosis
Organ transplantation
Peptides
Pneumonia
Pneumonitis
Prognosis
Pulmonary fibrosis
Pulmonary function tests
Respiratory function
Review
Tomography
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c570t-dcf4e86f2d21882cc81d2d4f1de987c47bd6b15ee2a3bd325b22ba09d1d129a83
cites
container_end_page 181
container_issue
container_start_page 171
container_title Journal of asthma and allergy
container_volume 9
creator Pereira, Carlos Ac
Gimenez, Andréa
Kuranishi, Lilian
Storrer, Karin
description Hypersensitivity pneumonitis (HSP) is a common interstitial lung disease resulting from inhalation of a large variety of antigens by susceptible individuals. The disease is best classified as acute and chronic. Chronic HSP can be fibrosing or not. Fibrotic HSP has a large differential diagnosis and has a worse prognosis. The most common etiologies for HSP are reviewed. Diagnostic criteria are proposed for both chronic forms based on exposure, lung auscultation, lung function tests, HRCT findings, bronchoalveolar lavage, and biopsies. Treatment options are limited, but lung transplantation results in greater survival in comparison to idiopathic pulmonary fibrosis. Randomized trials with new antifibrotic agents are necessary.
doi_str_mv 10.2147/JAA.S81540
format article
fullrecord <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_ab079a9b43aa4cf7837a637f1a730755</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A506650476</galeid><doaj_id>oai_doaj_org_article_ab079a9b43aa4cf7837a637f1a730755</doaj_id><sourcerecordid>A506650476</sourcerecordid><originalsourceid>FETCH-LOGICAL-c570t-dcf4e86f2d21882cc81d2d4f1de987c47bd6b15ee2a3bd325b22ba09d1d129a83</originalsourceid><addsrcrecordid>eNptkl1rFDEUhoNYbKm98QdIQZEi7JrvjxthWay2FHqhXodMktnJMpOsyUxh_71Zt9ZdaXKRwznPeQ85vAC8QXCOERWfbheL-XeJGIUvwBlCQs644uzlQXwKLkpZw3qI4pzwV-AUCwEJkfgMvF92OcVgL7vtxufiYwljeAjj9nIT_TTU0hjKa3DSmr74i8f3HPy8_vJj-W12d__1Zrm4m1km4DhztqVe8hY7jKTE1krksKMtcl5JYaloHG8Q8x4b0jiCWYNxY6ByyCGsjCTn4Gav65JZ600Og8lbnUzQfxIpr7TJY7C916aBQhnVUGIMta2QRBhORIuMIFAwVrU-77U2UzN4Z30cs-mPRI8rMXR6lR40g4QzhqvA1aNATr8mX0Y9hGJ935vo01Q0koQRjqjczXr3H7pOU451VRpjrChVCMl_1MrUD4TYpjrX7kT1gkHOGaSCV2r-DFWv80OwKfo21PxRw4eDhs6bfuxK6qcxpFiOwY970OZUSvbt0zIQ1Dsv6eolvfdShd8eru8J_esc8hvFOcDN</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2229449118</pqid></control><display><type>article</type><title>Chronic hypersensitivity pneumonitis</title><source>Taylor &amp; Francis Open Access</source><source>Publicly Available Content (ProQuest)</source><source>PubMed Central</source><creator>Pereira, Carlos Ac ; Gimenez, Andréa ; Kuranishi, Lilian ; Storrer, Karin</creator><creatorcontrib>Pereira, Carlos Ac ; Gimenez, Andréa ; Kuranishi, Lilian ; Storrer, Karin</creatorcontrib><description>Hypersensitivity pneumonitis (HSP) is a common interstitial lung disease resulting from inhalation of a large variety of antigens by susceptible individuals. The disease is best classified as acute and chronic. Chronic HSP can be fibrosing or not. Fibrotic HSP has a large differential diagnosis and has a worse prognosis. The most common etiologies for HSP are reviewed. Diagnostic criteria are proposed for both chronic forms based on exposure, lung auscultation, lung function tests, HRCT findings, bronchoalveolar lavage, and biopsies. Treatment options are limited, but lung transplantation results in greater survival in comparison to idiopathic pulmonary fibrosis. Randomized trials with new antifibrotic agents are necessary.</description><identifier>ISSN: 1178-6965</identifier><identifier>EISSN: 1178-6965</identifier><identifier>DOI: 10.2147/JAA.S81540</identifier><identifier>PMID: 27703382</identifier><language>eng</language><publisher>New Zealand: Dove Medical Press Limited</publisher><subject>Airway management ; Alveoli ; Alveolitis ; Antigens ; Bronchus ; Care and treatment ; Cluster analysis ; Cytokines ; Development and progression ; Differential diagnosis ; Disease susceptibility ; Extrinsic allergic alveolitis ; Fibrosis ; Hypersensitivity ; Hypersensitivity pneumonitis ; Inflammation ; Inhalation ; Lung diseases ; Lung transplantation ; Medical prognosis ; Organ transplantation ; Peptides ; Pneumonia ; Pneumonitis ; Prognosis ; Pulmonary fibrosis ; Pulmonary function tests ; Respiratory function ; Review ; Tomography</subject><ispartof>Journal of asthma and allergy, 2016-01, Vol.9, p.171-181</ispartof><rights>COPYRIGHT 2016 Dove Medical Press Limited</rights><rights>2016. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2016 Pereira et al. This work is published and licensed by Dove Medical Press Limited 2016</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c570t-dcf4e86f2d21882cc81d2d4f1de987c47bd6b15ee2a3bd325b22ba09d1d129a83</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2229449118/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2229449118?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25752,27923,27924,37011,37012,44589,53790,53792,74897</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27703382$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Pereira, Carlos Ac</creatorcontrib><creatorcontrib>Gimenez, Andréa</creatorcontrib><creatorcontrib>Kuranishi, Lilian</creatorcontrib><creatorcontrib>Storrer, Karin</creatorcontrib><title>Chronic hypersensitivity pneumonitis</title><title>Journal of asthma and allergy</title><addtitle>J Asthma Allergy</addtitle><description>Hypersensitivity pneumonitis (HSP) is a common interstitial lung disease resulting from inhalation of a large variety of antigens by susceptible individuals. The disease is best classified as acute and chronic. Chronic HSP can be fibrosing or not. Fibrotic HSP has a large differential diagnosis and has a worse prognosis. The most common etiologies for HSP are reviewed. Diagnostic criteria are proposed for both chronic forms based on exposure, lung auscultation, lung function tests, HRCT findings, bronchoalveolar lavage, and biopsies. Treatment options are limited, but lung transplantation results in greater survival in comparison to idiopathic pulmonary fibrosis. Randomized trials with new antifibrotic agents are necessary.</description><subject>Airway management</subject><subject>Alveoli</subject><subject>Alveolitis</subject><subject>Antigens</subject><subject>Bronchus</subject><subject>Care and treatment</subject><subject>Cluster analysis</subject><subject>Cytokines</subject><subject>Development and progression</subject><subject>Differential diagnosis</subject><subject>Disease susceptibility</subject><subject>Extrinsic allergic alveolitis</subject><subject>Fibrosis</subject><subject>Hypersensitivity</subject><subject>Hypersensitivity pneumonitis</subject><subject>Inflammation</subject><subject>Inhalation</subject><subject>Lung diseases</subject><subject>Lung transplantation</subject><subject>Medical prognosis</subject><subject>Organ transplantation</subject><subject>Peptides</subject><subject>Pneumonia</subject><subject>Pneumonitis</subject><subject>Prognosis</subject><subject>Pulmonary fibrosis</subject><subject>Pulmonary function tests</subject><subject>Respiratory function</subject><subject>Review</subject><subject>Tomography</subject><issn>1178-6965</issn><issn>1178-6965</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNptkl1rFDEUhoNYbKm98QdIQZEi7JrvjxthWay2FHqhXodMktnJMpOsyUxh_71Zt9ZdaXKRwznPeQ85vAC8QXCOERWfbheL-XeJGIUvwBlCQs644uzlQXwKLkpZw3qI4pzwV-AUCwEJkfgMvF92OcVgL7vtxufiYwljeAjj9nIT_TTU0hjKa3DSmr74i8f3HPy8_vJj-W12d__1Zrm4m1km4DhztqVe8hY7jKTE1krksKMtcl5JYaloHG8Q8x4b0jiCWYNxY6ByyCGsjCTn4Gav65JZ600Og8lbnUzQfxIpr7TJY7C916aBQhnVUGIMta2QRBhORIuMIFAwVrU-77U2UzN4Z30cs-mPRI8rMXR6lR40g4QzhqvA1aNATr8mX0Y9hGJ935vo01Q0koQRjqjczXr3H7pOU451VRpjrChVCMl_1MrUD4TYpjrX7kT1gkHOGaSCV2r-DFWv80OwKfo21PxRw4eDhs6bfuxK6qcxpFiOwY970OZUSvbt0zIQ1Dsv6eolvfdShd8eru8J_esc8hvFOcDN</recordid><startdate>20160101</startdate><enddate>20160101</enddate><creator>Pereira, Carlos Ac</creator><creator>Gimenez, Andréa</creator><creator>Kuranishi, Lilian</creator><creator>Storrer, Karin</creator><general>Dove Medical Press Limited</general><general>Taylor &amp; Francis Ltd</general><general>Dove Medical Press</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7XB</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>KB0</scope><scope>LK8</scope><scope>M2O</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20160101</creationdate><title>Chronic hypersensitivity pneumonitis</title><author>Pereira, Carlos Ac ; Gimenez, Andréa ; Kuranishi, Lilian ; Storrer, Karin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c570t-dcf4e86f2d21882cc81d2d4f1de987c47bd6b15ee2a3bd325b22ba09d1d129a83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Airway management</topic><topic>Alveoli</topic><topic>Alveolitis</topic><topic>Antigens</topic><topic>Bronchus</topic><topic>Care and treatment</topic><topic>Cluster analysis</topic><topic>Cytokines</topic><topic>Development and progression</topic><topic>Differential diagnosis</topic><topic>Disease susceptibility</topic><topic>Extrinsic allergic alveolitis</topic><topic>Fibrosis</topic><topic>Hypersensitivity</topic><topic>Hypersensitivity pneumonitis</topic><topic>Inflammation</topic><topic>Inhalation</topic><topic>Lung diseases</topic><topic>Lung transplantation</topic><topic>Medical prognosis</topic><topic>Organ transplantation</topic><topic>Peptides</topic><topic>Pneumonia</topic><topic>Pneumonitis</topic><topic>Prognosis</topic><topic>Pulmonary fibrosis</topic><topic>Pulmonary function tests</topic><topic>Respiratory function</topic><topic>Review</topic><topic>Tomography</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Pereira, Carlos Ac</creatorcontrib><creatorcontrib>Gimenez, Andréa</creatorcontrib><creatorcontrib>Kuranishi, Lilian</creatorcontrib><creatorcontrib>Storrer, Karin</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Nursing and Allied Health Journals</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Public Health Database (ProQuest Medical &amp; Health Databases)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Biological Sciences</collection><collection>ProQuest research library</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Publicly Available Content (ProQuest)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Journal of asthma and allergy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Pereira, Carlos Ac</au><au>Gimenez, Andréa</au><au>Kuranishi, Lilian</au><au>Storrer, Karin</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Chronic hypersensitivity pneumonitis</atitle><jtitle>Journal of asthma and allergy</jtitle><addtitle>J Asthma Allergy</addtitle><date>2016-01-01</date><risdate>2016</risdate><volume>9</volume><spage>171</spage><epage>181</epage><pages>171-181</pages><issn>1178-6965</issn><eissn>1178-6965</eissn><abstract>Hypersensitivity pneumonitis (HSP) is a common interstitial lung disease resulting from inhalation of a large variety of antigens by susceptible individuals. The disease is best classified as acute and chronic. Chronic HSP can be fibrosing or not. Fibrotic HSP has a large differential diagnosis and has a worse prognosis. The most common etiologies for HSP are reviewed. Diagnostic criteria are proposed for both chronic forms based on exposure, lung auscultation, lung function tests, HRCT findings, bronchoalveolar lavage, and biopsies. Treatment options are limited, but lung transplantation results in greater survival in comparison to idiopathic pulmonary fibrosis. Randomized trials with new antifibrotic agents are necessary.</abstract><cop>New Zealand</cop><pub>Dove Medical Press Limited</pub><pmid>27703382</pmid><doi>10.2147/JAA.S81540</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1178-6965
ispartof Journal of asthma and allergy, 2016-01, Vol.9, p.171-181
issn 1178-6965
1178-6965
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_ab079a9b43aa4cf7837a637f1a730755
source Taylor & Francis Open Access; Publicly Available Content (ProQuest); PubMed Central
subjects Airway management
Alveoli
Alveolitis
Antigens
Bronchus
Care and treatment
Cluster analysis
Cytokines
Development and progression
Differential diagnosis
Disease susceptibility
Extrinsic allergic alveolitis
Fibrosis
Hypersensitivity
Hypersensitivity pneumonitis
Inflammation
Inhalation
Lung diseases
Lung transplantation
Medical prognosis
Organ transplantation
Peptides
Pneumonia
Pneumonitis
Prognosis
Pulmonary fibrosis
Pulmonary function tests
Respiratory function
Review
Tomography
title Chronic hypersensitivity pneumonitis
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T02%3A42%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Chronic%20hypersensitivity%20pneumonitis&rft.jtitle=Journal%20of%20asthma%20and%20allergy&rft.au=Pereira,%20Carlos%20Ac&rft.date=2016-01-01&rft.volume=9&rft.spage=171&rft.epage=181&rft.pages=171-181&rft.issn=1178-6965&rft.eissn=1178-6965&rft_id=info:doi/10.2147/JAA.S81540&rft_dat=%3Cgale_doaj_%3EA506650476%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c570t-dcf4e86f2d21882cc81d2d4f1de987c47bd6b15ee2a3bd325b22ba09d1d129a83%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2229449118&rft_id=info:pmid/27703382&rft_galeid=A506650476&rfr_iscdi=true